Please Wait.....
Report
Oncology Information System Market by Product and Service, Application, End User (Hospitals & diagnostic imaging centers, Ablation & Cancer Care Centers, Government Institutions and Research Facilities) - Global Forecast to 2027
Market Report I 2022-06-03 I 341 Pages I MarketsandMarkets
Oncology information systems manage data from various treatment schedules, treatment plans, and treatment delivery for each patient. Focus on laying a framework on standardization in OIS is further advancing the level of care for each cancer patient through a multidisciplinary approach. Factors such as increasing adoption of OIS solutions to curtail the increasing cost of care and growing cases of cancer is expected to witness strong growth during forecasted period. For instance, as per National Cancer Institute, by 2040, the new cancer cases will rise by 29.5 million and the number of cancer related deaths to 16.4 million per year. Moreover, development of wide range of novel technologies will bring significant opportunities for oncology information system market during the forecast period.
"The Software segment held the largest share during the forecast period."
Software segment accounted for 83.6% of the oncology information system market for product and services in 2021. Software is a non-tangible component used to run a system or perform primary tasks, which include maintaining patient records and performing treatment planning in any healthcare organization or hospital. It is an integral part of the HCIT market and works as an interface between the database and end users. Healthcare organizations are moving from on-premise models to web- and cloud-based models, which fuels the growth of this segment during the forecast period.
"Radiation oncology segment held the largest share during the forecast period."
In 2021, the radiation oncology segment accounted for 53.8% of the oncology information system market for application. Radiation oncology specializes in treating cancer with radiation-delivering a high radiation dose directly to the tumor to kill cancer cells with minimum exposure to healthy tissue that surrounds the tumor. This limits complications, side-effects, and secondary effects to healthy tissues, which is driving advancements in radiation oncology. Some of the novel radiation oncology therapies that are widely used include external beam radiation therapy (EBRT), internal beam radiation therapy (IBRT), intraoperative radiation therapy (IORT), and brachytherapy. Integration of radiotherapy system with OIS enables clinicians to accelerate radiation dose calculation speed and improve the overall treatment planning efficiency.
"The hospitals and diagnostic imaging centers segment held the largest share during the forecast period."
In 2021, hospitals and diagnostic imaging centers accounted for 64.5% of the oncology information system market. Hospitals are the largest end-users of oncology information systems owing to the significant number of patient submissions/visits every year worldwide, increasing government initiatives aimed at equipping (or upgrading) hospitals with newer and advanced systems, increasing number of cancer care procedures, and the growing adoption of oncology treatment care. Growing burden of various types of cancers, and increasing number of diagnostic procedures performed globally are some of the factors driving the growth for diagnostic imagaing centers in oncology information system market.
"Asia Pacific projected to grow at the highest CAGR during the forecast period."
In 2021, the Asia Pacific accounted for 17.8% of the global oncology information system market. The growth of the APAC market is driven by several factors, such as the increasing investment for advancement of healthcare IT infrastructure, and increasing government support for implementation of healthcare IT solutions in healthcare settings. According to GLOBOCAN, in 2020, 883,395 new cases of cancer were recorded in Japan. The WHO estimates that the incidence of cancer in Japan can rise to 997,537 cases by 2040. The adoption of electronic medical records to use health information big data is a major priority in Japan. According to Japanese government, in 2019 the adoption rate for electronic medical records and ordering systems among hospitals was 34.4% and 43.6% respectively.
In-depth interviews were conducted with Chief Executive Officers (CEOs), marketing directors, other innovation and technology directors, and executives from various key organizations operating in the oncology information system market.
-?By Company Type: Tier 1: 46%, Tier 2: 33%, and Tier 3: 21%
-?By Designation: C-level Executives: 43%, Directors: 35%, and Others: 22%
-?By Region: North America: 30%, Europe: 35%, APAC: 24%, Latin America: 14% and Middle East & Africa: 4%
Prominent players in the oncology information system market are Koninklijke Philips N.V. (Netherlands), McKesson Corporation (US), Siemens Healthineers (Germany), Elekta AB (Sweden), Epic Systems Corporation (US), IBM (US), Cerner Corporation (US), Advanced Data Systems (US), Bogardus Medical Systems, Inc (US), F. Hoffmann-La Roche AG (Switzerland), Altai Oncology, LLC. (US), GE Healthcare (US), Accuray Incorporated (US), OPTUM (a part of UnitedHealth Group) (US), Allscripts Healthcare Solutions, Inc. (US), MICA Information Systems, Inc. (US), CureMD Healthcare (US), EndoSoft LLC (US), MIM Software Inc. (US) and RaySearch Laboratories AB (Sweden).
Research Coverage:
This report describes and studies the global oncology information system market based product and services, application, end user and regional level. It provides detailed information regarding the major factors influencing the growth of this market. The report includes an in-depth competitive analysis and the product matrix of the prominent players in this market, along with their company profiles, product portfolios, recent developments, and MNM overview.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the revenue numbers for the overall oncology information system market and its subsegments. This report will help stakeholders to understand the competitive landscape, to gain more insights to better position their businesses, and to plan suitable go-to-market strategies. The report will also help the stakeholders to understand the pulse of the market and provide information on key market drivers, restraints, opportunities, and challenges.
This report provides insights on:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the oncology information system market. The report analyzes this market by product and services, application, end user and region.
- Market Development: Comprehensive information on the lucrative emerging markets, by product and services, application, end user and region.
- Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the oncology information system market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the oncology information system market.
1 INTRODUCTION 38
1.1 OBJECTIVES OF THE STUDY 38
1.2 MARKET DEFINITION 38
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 39
1.3 MARKET SCOPE 39
1.3.1 MARKETS COVERED 40
FIGURE 1 ONCOLOGY INFORMATION SYSTEMS MARKET SEGMENTATION 40
1.3.2 YEARS CONSIDERED FOR THE STUDY 41
1.4 CURRENCY 41
TABLE 1 STANDARD CURRENCY CONVERSION RATES 41
1.5 LIMITATIONS 42
1.6 STAKEHOLDERS 42
1.7 SUMMARY OF CHANGES 42
2 RESEARCH METHODOLOGY 44
2.1 RESEARCH APPROACH 44
FIGURE 2 RESEARCH DESIGN 44
2.1.1 SECONDARY DATA 45
2.1.1.1 Key data from secondary sources 45
2.1.2 SECONDARY RESEARCH 46
2.1.3 PRIMARY RESEARCH 47
FIGURE 3 PRIMARY SOURCES 47
2.1.3.1 Key data from primary sources 48
FIGURE 4 INSIGHTS FROM INDUSTRY EXPERTS 48
2.1.3.2 Breakdown of primary sources 49
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 49
FIGURE 6 PRIMARY SOURCES 49
2.2 MARKET SIZE ESTIMATION 50
2.2.1 BOTTOM-UP APPROACH 50
FIGURE 7 ONCOLOGY INFORMATION SYSTEMS MARKET: BOTTOM-UP APPROACH 51
2.2.2 TOP-DOWN APPROACH 51
FIGURE 8 ONCOLOGY INFORMATION SYSTEMS MARKET: TOP-DOWN APPROACH 51
FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 52
FIGURE 10 ONCOLOGY INFORMATION SYSTEMS MARKET (2021): SUPPLY-SIDE MARKET SIZE ESTIMATION 53
FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 54
FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ONCOLOGY INFORMATION SYSTEMS MARKET (2022-2027) 54
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 56
FIGURE 13 DATA TRIANGULATION METHODOLOGY 56
2.4 MARKET SHARE ESTIMATION 56
2.5 ASSUMPTIONS FOR THE STUDY 57
2.6 RISK ASSESSMENT 57
TABLE 2 RISK ASSESSMENT: ONCOLOGY INFORMATION SYSTEMS MARKET 57
3 EXECUTIVE SUMMARY 58
FIGURE 14 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2022 VS. 2027 (USD MILLION) 58
FIGURE 15 ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 59
FIGURE 16 PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 60
FIGURE 17 TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 61
FIGURE 18 TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 62
FIGURE 19 ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 63
FIGURE 20 ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 64
FIGURE 21 ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 65
FIGURE 22 GEOGRAPHICAL SNAPSHOT OF THE ONCOLOGY INFORMATION SYSTEMS MARKET 66
4 PREMIUM INSIGHTS 68
4.1 ONCOLOGY INFORMATION SYSTEMS MARKET OVERVIEW 68
FIGURE 23 INCREASING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH 68
4.2 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE (2022-2027) 69
FIGURE 24 CONSULTING & OPTIMIZATION SERVICES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 69
4.3 APAC: ONCOLOGY INFORMATION SYSTEMS MARKET SHARE,
BY APPLICATION AND COUNTRY (2021) 70
FIGURE 25 RADIATION ONCOLOGY SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021 70
4.4 ONCOLOGY INFORMATION SYSTEMS MARKET: DEVELOPED VS. DEVELOPING MARKETS (USD MILLION) 71
FIGURE 26 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 71
4.5 ONCOLOGY INFORMATION SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 72
FIGURE 27 CHINA TO WITNESS HIGHEST GROWTH FROM 2022 TO 2027 72
?
5 MARKET OVERVIEW 73
5.1 INTRODUCTION 73
5.2 MARKET DYNAMICS 73
FIGURE 28 ONCOLOGY INFORMATION SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 73
5.2.1 DRIVERS 74
5.2.1.1 Need to curtail oncology care costs 74
FIGURE 29 GLOBAL ONCOLOGY SPENDING, 2015-2021 (USD BILLION) 74
5.2.1.2 Growing adoption of EHRs and other oncology healthcare IT solutions to improve care quality 75
FIGURE 30 PERCENTAGE OF PRIMARY CARE PHYSICIANS IN SELECTED COUNTRIES USING ELECTRONIC MEDICAL RECORDS (2019) 75
5.2.1.3 Increasing incidence and prevalence of cancer 76
TABLE 3 CANCER INCIDENCE PER MILLION POPULATION, BY COUNTRY, 2016-2020 76
5.2.1.4 Favorable government mandates and support for oncology information systems 77
5.2.1.5 Potential benefits of and technological advancements in oncology information systems 78
5.2.2 RESTRAINTS 79
5.2.2.1 Interoperability issues 79
5.2.2.2 Dearth of skilled IT professionals in healthcare industry 80
5.2.3 OPPORTUNITIES 81
5.2.3.1 Growing healthcare IT Industry 81
5.2.3.2 Integration of EMR with treatment planning systems 81
5.2.4 CHALLENGES 82
5.2.4.1 Concerns regarding data privacy 82
6 INDUSTRY INSIGHTS 83
6.1 INTRODUCTION 83
6.2 TECHNOLOGY ANALYSIS: ONCOLOGY INFORMATION SYSTEMS 83
6.2.1 ARTIFICIAL INTELLIGENCE 83
6.2.2 MACHINE LEARNING 83
6.2.3 INTERNET OF THINGS 83
6.2.4 BLOCKCHAIN 84
6.3 PRICING ANALYSIS: ONCOLOGY INFORMATION SYSTEMS 84
6.4 ECOSYSTEM LANDSCAPE: ONCOLOGY INFORMATION SYSTEMS MARKET 84
FIGURE 31 ONCOLOGY INFORMATION SYSTEMS MARKET: ECOSYSTEM 85
6.5 REGULATORY ANALYSIS 86
6.5.1 NORTH AMERICA 86
6.5.2 EUROPE 87
6.5.3 ASIA PACIFIC 87
6.5.4 MIDDLE EAST & AFRICA 88
6.5.5 LATIN AMERICA 88
6.6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88
TABLE 4 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 88
TABLE 5 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 89
TABLE 6 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
TABLE 7 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90
TABLE 8 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91
6.7 PORTER'S FIVE FORCES ANALYSIS 91
FIGURE 32 DEGREE OF COMPETITION IS HIGH IN THE ONCOLOGY INFORMATION SYSTEMS MARKET 91
TABLE 9 ONCOLOGY INFORMATION SYSTEMS MARKET: PORTER'S FIVE FORCES ANALYSIS 92
6.7.1 THREAT OF NEW ENTRANTS 92
6.7.2 THREAT OF SUBSTITUTES 93
6.7.3 BARGAINING POWER OF SUPPLIERS 93
6.7.4 BARGAINING POWER OF BUYERS 93
6.7.5 INTENSITY OF COMPETITIVE RIVALRY 93
6.8 KEY STAKEHOLDERS & BUYING CRITERIA 94
6.8.1 KEY STAKEHOLDERS IN BUYING PROCESS 94
FIGURE 33 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR ONCOLOGY INFORMATION SYSTEMS 94
TABLE 10 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS 94
6.9 KEY BUYING CRITERIA BY END USERS 95
FIGURE 34 BUYING CRITERIA OF END USERS 95
TABLE 11 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 95
6.10 PATENT ANALYSIS 96
6.10.1 PATENT PUBLICATION TRENDS FOR ONCOLOGY INFORMATION SYSTEMS 96
FIGURE 35 GLOBAL PATENT PUBLICATION TRENDS IN ONCOLOGY INFORMATION SYSTEMS MARKET, 2018-2022 96
6.10.2 TOP APPLICANTS (COMPANIES) FOR ONCOLOGY INFORMATION SYSTEM PATENTS 97
FIGURE 36 TOP COMPANIES THAT APPLIED FOR ONCOLOGY INFORMATION SYSTEM PATENTS, 2018-2022 97
6.11 KEY CONFERENCES & EVENTS IN 2022-2023 97
TABLE 12 ONCOLOGY INFORMATION SYSTEMS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 97
6.12 COVID-19 IMPACT ON ONCOLOGY INFORMATION SYSTEMS MARKET 99
?
7 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE 100
7.1 INTRODUCTION 101
TABLE 13 ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 101
7.2 SOFTWARE 101
TABLE 14 ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020-2027 (USD MILLION) 102
TABLE 15 ONCOLOGY INFORMATION SOFTWARE MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 103
7.2.1 PATIENT INFORMATION SYSTEMS 103
TABLE 16 PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 104
TABLE 17 PATIENT INFORMATION SYSTEMS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 105
7.2.1.1 Oncology electronic medical records 105
7.2.1.1.1 Adoption of oncology electronic medical records is growing significantly in emerging countries 105
TABLE 18 KEY PLAYERS OFFERING ONCOLOGY ELECTRONIC MEDICAL RECORDS 106
TABLE 19 ONCOLOGY ELECTRONIC MEDICAL RECORDS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 107
7.2.1.2 Laboratory information systems 107
7.2.1.2.1 Need for accurate, efficient, and rapid transfer of lab results across networks to drive market growth 107
TABLE 20 KEY PLAYERS OFFERING LABORATORY INFORMATION SYSTEMS 108
TABLE 21 LABORATORY INFORMATION SYSTEMS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 108
7.2.1.3 Radiology information systems 109
7.2.1.3.1 Integration of RIS with HIS and PACS has attracted attention from stakeholders 109
TABLE 22 KEY PLAYERS OFFERING RADIOLOGY INFORMATION SYSTEMS 109
TABLE 23 RADIOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 110
7.2.1.4 Chemotherapy information systems 110
7.2.1.4.1 Chemotherapy is increasingly being adopted as primary mode of treatment for various cancer types 110
TABLE 24 KEY PLAYERS OFFERING CHEMOTHERAPY INFORMATION SYSTEMS 111
TABLE 25 CHEMOTHERAPY INFORMATION SYSTEMS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 111
7.2.2 TREATMENT PLANNING SYSTEMS 112
TABLE 26 TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 112
TABLE 27 TREATMENT PLANNING SYSTEMS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 113
7.2.2.1 Radiotherapy treatment planning systems 113
7.2.2.1.1 Radiotherapy treatment planning systems to witness increased adoption for treatment of deep-seated tumors 113
TABLE 28 KEY MARKET PLAYERS OFFERING RADIOTHERAPY TREATMENT PLANNING SOLUTIONS 114
TABLE 29 RADIOTHERAPY TREATMENT PLANNING SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 115
7.2.2.2 Clinical decision support systems 115
7.2.2.2.1 Need to minimize errors and ensure regulatory compliance to drive adoption of CDSS 115
TABLE 30 KEY PLAYERS OFFERING CLINICAL DECISION SUPPORT SYSTEMS 116
TABLE 31 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 117
7.2.2.3 Brachytherapy treatment planning systems 117
7.2.2.3.1 Better patient care with pulsed-dose rate brachytherapy to drive demand for these systems 117
TABLE 32 BRACHYTHERAPY TREATMENT PLANNING SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 118
7.2.3 TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS 119
TABLE 33 TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 119
TABLE 34 TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 120
7.2.3.1 Population health management solutions 120
7.2.3.1.1 PHM solutions aggregate and provide wide range of cancer data for providers 120
TABLE 35 KEY PLAYERS OFFERING POPULATION HEALTH MANAGEMENT SOLUTIONS 121
TABLE 36 POPULATION HEALTH MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 122
7.2.3.2 Clinical integration solutions 122
7.2.3.2.1 Increasing number of cancer patient admissions in inpatient facilities is key factor driving market growth 122
TABLE 37 KEY PLAYERS OFFERING CLINICAL INTEGRATION SOLUTIONS 123
TABLE 38 CLINICAL INTEGRATION SOLUTIONS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 124
7.2.3.3 Picture archiving and communication systems & vendor-neutral archive solutions 124
7.2.3.3.1 Rising demand for PACS and increasing generation of image data will ensure sustained demand for these solutions 124
TABLE 39 KEY PLAYERS OFFERING PICTURE ARCHIVING AND COMMUNICATION SYSTEMS & VENDOR-NEUTRAL ARCHIVE SOLUTIONS 126
TABLE 40 PICTURE ARCHIVING AND COMMUNICATION SYSTEMS & VENDOR-NEUTRAL ARCHIVE SOLUTIONS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 127
7.2.3.4 Advanced visualization & image analysis solutions 127
7.2.3.4.1 Increasing demand for imaging modalities in various indications of oncology to drive segment growth 127
TABLE 41 ADVANCED VISUALIZATION & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 129
7.2.3.5 Radiation dose management solutions 129
7.2.3.5.1 Use of these solutions enables optimization of radiation dose administration and management 129
TABLE 42 KEY PLAYERS OFFERING RADIATION DOSE MANAGEMENT SOLUTIONS 130
TABLE 43 RADIATION DOSE MANAGEMENT SOLUTIONS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 131
7.3 PROFESSIONAL SERVICES 131
TABLE 44 ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 132
TABLE 45 ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 133
7.3.1 IMPLEMENTATION SERVICES 133
7.3.1.1 Healthcare organizations are increasingly outsourcing implementation services 133
TABLE 46 KEY PLAYERS OFFERING IMPLEMENTATION SERVICES 134
TABLE 47 IMPLEMENTATION SERVICES MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 134
7.3.2 POST-SALE & MAINTENANCE SERVICES 135
7.3.2.1 Rising trend of outsourcing is driving market for post-sale & maintenance services 135
TABLE 48 KEY PLAYERS OFFERING POST-SALE & MAINTENANCE SERVICES 135
TABLE 49 POST-SALE & MAINTENANCE SERVICES MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 136
7.3.3 CONSULTING & OPTIMIZATION SERVICES 136
7.3.3.1 Consulting services deliver optimum guidance to healthcare providers for implementing oncology information solutions 136
TABLE 50 KEY PLAYERS OFFERING CONSULTING SERVICES 137
TABLE 51 CONSULTING & OPTIMIZATION SERVICES MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 138
8 ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION 139
8.1 INTRODUCTION 140
TABLE 52 ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION,
2020-2027 (USD MILLION) 140
8.2 RADIATION ONCOLOGY 140
8.2.1 INTRODUCTION OF AI-BASED RADIOTHERAPY TREATMENT PLANNING SYSTEMS TO DRIVE MARKET GROWTH 140
TABLE 53 US: RADIATION-TREATED CANCER SURVIVORS, 2016-2030 (THOUSAND) 141
TABLE 54 KEY PRODUCTS IN RADIATION ONCOLOGY MARKET 142
TABLE 55 ONCOLOGY INFORMATION SYSTEMS MARKET FOR RADIATION ONCOLOGY,
BY COUNTRY, 2020-2027 (USD MILLION) 143
8.3 MEDICAL ONCOLOGY 143
8.3.1 RISING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH 143
TABLE 56 KEY PRODUCTS IN MEDICAL ONCOLOGY MARKET 144
FIGURE 37 NUMBER OF ONCOLOGY CLINICAL TRIALS WORLDWIDE, 2012-2018 144
TABLE 57 ONCOLOGY INFORMATION SYSTEMS MARKET FOR MEDICAL ONCOLOGY,
BY COUNTRY, 2020-2027 (USD MILLION) 145
8.4 SURGICAL ONCOLOGY 145
8.4.1 NEED FOR STRUCTURED HEALTHCARE INFORMATION SYSTEMS TO BOOST MARKET GROWTH 145
TABLE 58 KEY PRODUCTS IN SURGICAL ONCOLOGY MARKET 146
TABLE 59 ONCOLOGY INFORMATION SYSTEMS MARKET FOR SURGICAL ONCOLOGY,
BY COUNTRY, 2020-2027 (USD MILLION) 146
9 ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER 147
9.1 INTRODUCTION 148
TABLE 60 ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER,
2020-2027 (USD MILLION) 148
9.2 HOSPITALS & DIAGNOSTIC IMAGING CENTERS 148
9.2.1 HOSPITALS & DIAGNOSTIC IMAGING CENTERS ARE LARGEST END USERS OF ONCOLOGY INFORMATION SYSTEMS 148
TABLE 61 NUMBER OF HOSPITALS, BY COUNTRY (2021) 149
TABLE 62 ONCOLOGY INFORMATION SYSTEMS MARKET FOR HOSPITALS & DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2020-2027 (USD MILLION) 150
9.3 ABLATION & CANCER CARE CENTERS 150
9.3.1 INITIATION OF CANCER CARE PROGRAMS AND SUPPORTING REIMBURSEMENT PLANS TO BOOST SEGMENT GROWTH 150
TABLE 63 ONCOLOGY INFORMATION SYSTEMS MARKET FOR ABLATION & CANCER CARE CENTERS, BY COUNTRY, 2020-2027 (USD MILLION) 151
9.4 GOVERNMENT INSTITUTES 152
9.4.1 RISING GOVERNMENT INITIATIVES TO DRIVE MARKET GROWTH 152
TABLE 64 ONCOLOGY INFORMATION SYSTEMS MARKET FOR GOVERNMENT INSTITUTES, BY COUNTRY, 2020-2027 (USD MILLION) 153
9.5 RESEARCH FACILITIES 153
9.5.1 GROWING NUMBER OF CANCER RESEARCH STUDIES TO DRIVE MARKET GROWTH 153
TABLE 65 ONCOLOGY INFORMATION SYSTEMS MARKET FOR RESEARCH FACILITIES,
BY COUNTRY, 2020-2027 (USD MILLION) 154
10 ONCOLOGY INFORMATION SYSTEMS MARKET, BY REGION 155
10.1 INTRODUCTION 156
FIGURE 38 ONCOLOGY INFORMATION SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 156
TABLE 66 ONCOLOGY INFORMATION SYSTEMS MARKET, BY REGION,
2020-2027 (USD MILLION) 157
10.2 NORTH AMERICA 157
FIGURE 39 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET SNAPSHOT 158
TABLE 67 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY COUNTRY, 2020-2027 (USD MILLION) 159
TABLE 68 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 159
TABLE 69 NORTH AMERICA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION) 160
TABLE 70 NORTH AMERICA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 160
TABLE 71 NORTH AMERICA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 161
TABLE 72 NORTH AMERICA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 161
TABLE 73 NORTH AMERICA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 162
TABLE 74 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY APPLICATION, 2020-2027 (USD MILLION) 162
TABLE 75 NORTH AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY END USER, 2020-2027 (USD MILLION) 163
10.2.1 US 163
10.2.1.1 Rising adoption of oncology information systems in hospitals to drive market growth 163
FIGURE 40 US: HOSPITAL EHR ADOPTION (2010-2018) 164
TABLE 76 US: KEY MACROINDICATORS 165
TABLE 77 US: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 165
TABLE 78 US: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020-2027 (USD MILLION) 166
TABLE 79 US: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 166
TABLE 80 US: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 167
TABLE 81 US: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 167
TABLE 82 US: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 168
10.2.2 CANADA 168
10.2.2.1 Deployment of digital healthcare initiatives is boosting market growth in Canada 168
FIGURE 41 CANADA: EMR ADOPTION BY PRIMARY CARE PHYSICIANS,
2013-2018 169
TABLE 83 CANADA: KEY MACROINDICATORS 170
TABLE 84 CANADA: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 170
TABLE 85 CANADA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020-2027 (USD MILLION) 171
TABLE 86 CANADA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 171
TABLE 87 CANADA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 172
TABLE 88 CANADA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 172
TABLE 89 CANADA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,
BY TYPE, 2020-2027 (USD MILLION) 173
?
10.3 EUROPE 173
FIGURE 42 EUROPE: CANCER PREVALENCE, BY COUNTRY, 2012-2030 174
TABLE 90 EUROPE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY,
2020-2027 (USD MILLION) 175
TABLE 91 EUROPE: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 175
TABLE 92 EUROPE: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020-2027 (USD MILLION) 176
TABLE 93 EUROPE: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 176
TABLE 94 EUROPE: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 177
TABLE 95 EUROPE: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 177
TABLE 96 EUROPE: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,
BY TYPE, 2020-2027 (USD MILLION) 178
TABLE 97 EUROPE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 178
TABLE 98 EUROPE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2020-2027 (USD MILLION) 179
10.3.1 GERMANY 179
10.3.1.1 High adoption of EHR systems among healthcare practitioners to drive market growth in Germany 179
TABLE 99 GERMANY: KEY MACROINDICATORS 180
TABLE 100 GERMANY: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 181
TABLE 101 GERMANY: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020-2027 (USD MILLION) 181
TABLE 102 GERMANY: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 182
TABLE 103 GERMANY: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 182
TABLE 104 GERMANY: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 183
TABLE 105 GERMANY: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,
BY TYPE, 2020-2027 (USD MILLION) 183
10.3.2 UK 184
10.3.2.1 UK is rapidly transforming its organizations into paperless environments through EHRs 184
TABLE 106 UK: KEY MACROINDICATORS 184
TABLE 107 UK: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 185
TABLE 108 UK: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020-2027 (USD MILLION) 185
TABLE 109 UK: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 186
TABLE 110 UK: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 186
TABLE 111 UK: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 187
TABLE 112 UK: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 187
10.3.3 FRANCE 188
10.3.3.1 Growing reforms in digital health will support market growth 188
TABLE 113 FRANCE: KEY MACROINDICATORS 188
TABLE 114 FRANCE: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 189
TABLE 115 FRANCE: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020-2027 (USD MILLION) 189
TABLE 116 FRANCE: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 190
TABLE 117 FRANCE: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 190
TABLE 118 FRANCE: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 191
TABLE 119 FRANCE: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,
BY TYPE, 2020-2027 (USD MILLION) 191
10.3.4 ITALY 192
10.3.4.1 Increasing government initiatives and reforms to drive market growth 192
TABLE 120 ITALY: KEY MACROINDICATORS 192
TABLE 121 ITALY: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 193
TABLE 122 ITALY: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020-2027 (USD MILLION) 193
TABLE 123 ITALY: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 194
TABLE 124 ITALY: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 194
TABLE 125 ITALY: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 195
TABLE 126 ITALY: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,
BY TYPE, 2020-2027 (USD MILLION) 195
10.3.5 SPAIN 196
10.3.5.1 Increasing prevalence of cancer to drive adoption of oncology information systems 196
TABLE 127 SPAIN: KEY MACROINDICATORS 196
TABLE 128 SPAIN: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 197
TABLE 129 SPAIN: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020-2027 (USD MILLION) 197
TABLE 130 SPAIN: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 198
TABLE 131 SPAIN: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 198
TABLE 132 SPAIN: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 199
TABLE 133 SPAIN: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,
BY TYPE, 2020-2027 (USD MILLION) 199
10.3.6 REST OF EUROPE 200
TABLE 134 ROE: ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 201
TABLE 135 ROE: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020-2027 (USD MILLION) 201
TABLE 136 ROE: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 202
TABLE 137 ROE: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 202
TABLE 138 ROE: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 203
TABLE 139 ROE: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 203
10.4 ASIA PACIFIC 204
FIGURE 43 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET SNAPSHOT 205
TABLE 140 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 206
TABLE 141 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 206
TABLE 142 ASIA PACIFIC: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION) 207
TABLE 143 ASIA PACIFIC: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 207
TABLE 144 ASIA PACIFIC: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 208
TABLE 145 ASIA PACIFIC: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 208
TABLE 146 ASIA PACIFIC: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 209
TABLE 147 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY APPLICATION, 2020-2027 (USD MILLION) 209
TABLE 148 ASIA PACIFIC: ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2020-2027 (USD MILLION) 210
10.4.1 JAPAN 210
10.4.1.1 Japan dominates Asia Pacific oncology information systems market 210
TABLE 149 JAPAN: KEY MACROINDICATORS 211
TABLE 150 JAPAN: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 211
TABLE 151 JAPAN: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020-2027 (USD MILLION) 212
TABLE 152 JAPAN: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 212
TABLE 153 JAPAN: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 213
TABLE 154 JAPAN: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 213
TABLE 155 JAPAN: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,
BY TYPE, 2020-2027 (USD MILLION) 214
10.4.2 CHINA 214
10.4.2.1 Strong government support in China to propel market growth 214
TABLE 156 CHINA: KEY MACROINDICATORS 215
TABLE 157 CHINA: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 215
TABLE 158 CHINA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020-2027 (USD MILLION) 216
TABLE 159 CHINA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 216
TABLE 160 CHINA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 217
TABLE 161 CHINA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 217
TABLE 162 CHINA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,
BY TYPE, 2020-2027 (USD MILLION) 218
10.4.3 INDIA 218
10.4.3.1 Rising need for cost-effective technologies has increased demand for oncology information solutions in India 218
TABLE 163 INDIA: KEY MACROINDICATORS 219
TABLE 164 INDIA: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 219
TABLE 165 INDIA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020-2027 (USD MILLION) 220
TABLE 166 INDIA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 220
TABLE 167 INDIA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 221
TABLE 168 INDIA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 221
TABLE 169 INDIA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,
BY TYPE, 2020-2027 (USD MILLION) 222
10.4.4 AUSTRALIA 222
10.4.4.1 Supportive government initiatives and strategic developments by market players to drive market growth 222
TABLE 170 AUSTRALIA: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 223
TABLE 171 AUSTRALIA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020-2027 (USD MILLION) 224
TABLE 172 AUSTRALIA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 224
TABLE 173 AUSTRALIA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 225
TABLE 174 AUSTRALIA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 225
TABLE 175 AUSTRALIA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 226
10.4.5 SOUTH KOREA 226
10.4.5.1 Increasing adoption of oncology information systems to positively impact market growth 226
TABLE 176 SOUTH KOREA: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 227
TABLE 177 SOUTH KOREA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION) 227
TABLE 178 SOUTH KOREA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 228
TABLE 179 SOUTH KOREA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 228
TABLE 180 SOUTH KOREA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 229
TABLE 181 SOUTH KOREA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 229
10.4.6 REST OF ASIA PACIFIC 230
TABLE 182 ROAPAC: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 230
TABLE 183 ROAPAC: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020-2027 (USD MILLION) 231
TABLE 184 ROAPAC: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 231
TABLE 185 ROAPAC: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 232
TABLE 186 ROAPAC: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 232
TABLE 187 ROAPAC: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,
BY TYPE, 2020-2027 (USD MILLION) 233
10.5 LATIN AMERICA 233
TABLE 188 LATIN AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 233
TABLE 189 LATIN AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 234
TABLE 190 LATIN AMERICA: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE, 2020-2027 (USD MILLION) 234
TABLE 191 LATIN AMERICA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 235
TABLE 192 LATIN AMERICA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 235
TABLE 193 LATIN AMERICA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 236
TABLE 194 LATIN AMERICA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 236
TABLE 195 LATIN AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY APPLICATION, 2020-2027 (USD MILLION) 237
TABLE 196 LATIN AMERICA: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY END USER, 2020-2027 (USD MILLION) 237
?
10.5.1 BRAZIL 238
10.5.1.1 Modernization of healthcare infrastructure to drive market growth 238
TABLE 197 BRAZIL: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 238
TABLE 198 BRAZIL: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020-2027 (USD MILLION) 239
TABLE 199 BRAZIL: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 239
TABLE 200 BRAZIL: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 240
TABLE 201 BRAZIL: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 240
TABLE 202 BRAZIL: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,
BY TYPE, 2020-2027 (USD MILLION) 241
10.5.2 MEXICO 241
10.5.2.1 Favorable government initiatives and growing medical tourism to drive market growth 241
TABLE 203 MEXICO: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 242
TABLE 204 MEXICO: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020-2027 (USD MILLION) 242
TABLE 205 MEXICO: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 243
TABLE 206 MEXICO: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 243
TABLE 207 MEXICO: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 244
TABLE 208 MEXICO: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,
BY TYPE, 2020-2027 (USD MILLION) 244
10.5.3 REST OF LATIN AMERICA 245
TABLE 209 ROLATAM: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 245
TABLE 210 ROLATAM: ONCOLOGY INFORMATION SOFTWARE MARKET, BY TYPE,
2020-2027 (USD MILLION) 246
TABLE 211 ROLATAM: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 246
TABLE 212 ROLATAM: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE,
2020-2027 (USD MILLION) 247
TABLE 213 ROLATAM: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 247
TABLE 214 ROLATAM: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET,
BY TYPE, 2020-2027 (USD MILLION) 248
10.6 MIDDLE EAST & AFRICA 248
10.6.1 INCREASING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH 248
TABLE 215 MIDDLE EAST & AFRICA: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY PRODUCT & SERVICE, 2020-2027 (USD MILLION) 249
TABLE 216 MIDDLE EAST & AFRICA: ONCOLOGY INFORMATION SOFTWARE MARKET,
BY TYPE, 2020-2027 (USD MILLION) 249
TABLE 217 MIDDLE EAST & AFRICA: PATIENT INFORMATION SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 250
TABLE 218 MIDDLE EAST & AFRICA: TREATMENT PLANNING SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 250
TABLE 219 MIDDLE EAST & AFRICA: TREATMENT MANAGEMENT SYSTEMS & MEDICAL IMAGE ANALYSIS SYSTEMS MARKET, BY TYPE, 2020-2027 (USD MILLION) 251
TABLE 220 MIDDLE EAST & AFRICA: ONCOLOGY INFORMATION PROFESSIONAL SERVICES MARKET, BY TYPE, 2020-2027 (USD MILLION) 251
TABLE 221 MIDDLE EAST & AFRICA: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY APPLICATION, 2020-2027 (USD MILLION) 252
TABLE 222 MIDDLE EAST & AFRICA: ONCOLOGY INFORMATION SYSTEMS MARKET,
BY END USER, 2020-2027 (USD MILLION) 252
11 COMPETITIVE LANDSCAPE 253
11.1 OVERVIEW 253
11.2 KEY DEVELOPMENTS BY LEADING PLAYERS IN ONCOLOGY INFORMATION SYSTEMS MARKET, JANUARY 2018-APRIL 2022 254
11.3 KEY PLAYER STRATEGIES/RIGHT TO WIN 255
11.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 255
FIGURE 44 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 255
TABLE 223 ONCOLOGY INFORMATION SYSTEMS MARKET: DEGREE OF COMPETITION 256
11.5 MARKET RANKING ANALYSIS 256
FIGURE 45 RANK OF COMPANIES IN GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET (2021) 256
11.6 COMPETITIVE LEADERSHIP MAPPING 258
11.6.1 STARS 258
11.6.2 EMERGING LEADERS 258
11.6.3 PERVASIVE PLAYERS 258
11.6.4 PARTICIPANTS 258
FIGURE 46 ONCOLOGY INFORMATION SYSTEMS MARKET: COMPETITIVE LEADERSHIP MAPPING (2021) 259
11.7 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES 260
11.7.1 PROGRESSIVE COMPANIES 260
11.7.2 STARTING BLOCKS 260
11.7.3 RESPONSIVE COMPANIES 260
11.7.4 DYNAMIC COMPANIES 260
FIGURE 47 ONCOLOGY INFORMATION SYSTEMS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2021) 261
11.8 COMPETITIVE BENCHMARKING 262
TABLE 224 ONCOLOGY INFORMATION SYSTEMS MARKET: SUPPORTING DATA OF KEY START-UPS/SMES 262
11.9 COMPETITIVE BENCHMARKING FOR STARTUPS/SMES 263
TABLE 225 ONCOLOGY INFORMATION SYSTEMS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 263
?
11.10 ONCOLOGY INFORMATION SYSTEMS MARKET: R&D EXPENDITURE 264
FIGURE 48 R&D EXPENDITURE OF KEY PLAYERS IN ONCOLOGY INFORMATION SYSTEMS MARKET (2020 VS. 2021) 264
11.11 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS 265
FIGURE 49 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN ONCOLOGY INFORMATION SYSTEMS MARKET 265
11.12 COMPANY REGIONAL FOOTPRINT 266
TABLE 226 COMPANY REGIONAL FOOTPRINT 266
TABLE 227 COMPANY SOFTWARE FOOTPRINT 267
TABLE 228 COMPANY SERVICE FOOTPRINT 268
TABLE 229 COMPANY APPLICATION FOOTPRINT 268
11.13 COMPETITIVE SITUATION AND TRENDS 269
11.13.1 PRODUCT LAUNCHES 269
TABLE 230 ONCOLOGY INFORMATION SYSTEMS MARKET: KEY PRODUCT LAUNCHES 269
11.13.2 DEALS 270
TABLE 231 ONCOLOGY INFORMATION SYSTEMS MARKET: KEY DEALS 270
11.13.3 OTHER DEVELOPMENTS 271
TABLE 232 ONCOLOGY INFORMATION SYSTEMS MARKET: OTHER KEY DEVELOPMENTS 271
12 COMPANY PROFILES 272
12.1 KEY PLAYERS 272
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.1.1 KONINKLIJKE PHILIPS N.V. 272
TABLE 233 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 272
FIGURE 50 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2021) 273
12.1.2 SIEMENS HEALTHINEERS 280
TABLE 234 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW 280
FIGURE 51 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2021) 281
12.1.3 ELEKTA 285
TABLE 235 ELEKTA: BUSINESS OVERVIEW 285
FIGURE 52 ELEKTA: COMPANY SNAPSHOT (2021) 286
12.1.4 GE HEALTHCARE 292
TABLE 236 GE HEALTHCARE: BUSINESS OVERVIEW 292
FIGURE 53 GE HEALTHCARE: COMPANY SNAPSHOT (2021) 293
12.1.5 MCKESSON CORPORATION 297
TABLE 237 MCKESSON CORPORATION: BUSINESS OVERVIEW 297
FIGURE 54 MCKESSON CORPORATION: COMPANY SNAPSHOT (2021) 298
12.2 OTHER PLAYERS 301
12.2.1 CERNER CORPORATION 301
TABLE 238 CERNER CORPORATION: BUSINESS OVERVIEW 301
FIGURE 55 CERNER CORPORATION: COMPANY SNAPSHOT (2021) 302
12.2.2 ACCURAY INCORPORATED 305
TABLE 239 ACCURAY INCORPORATED: BUSINESS OVERVIEW 305
FIGURE 56 ACCURAY INCORPORATED: COMPANY SNAPSHOT (2021) 306
12.2.3 ALLSCRIPTS HEALTHCARE, LLC 308
TABLE 240 ALLSCRIPTS HEALTHCARE, LLC.: BUSINESS OVERVIEW 308
FIGURE 57 ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT (2021) 309
12.2.4 IBM 312
TABLE 241 IBM: BUSINESS OVERVIEW 312
FIGURE 58 IBM: COMPANY SNAPSHOT (2021) 313
12.2.5 F. HOFFMANN-LA ROCHE AG 318
TABLE 242 F. HOFFMANN-LA ROCHE AG: BUSINESS OVERVIEW 318
FIGURE 59 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2021) 319
12.2.6 EPIC SYSTEMS CORPORATION 322
TABLE 243 EPIC SYSTEMS CORPORATION: BUSINESS OVERVIEW 322
12.2.7 RAYSEARCH LABORATORIES 324
TABLE 244 RAYSEARCH LABORATORIES: BUSINESS OVERVIEW 324
FIGURE 60 RAYSEARCH LABORATORIES: COMPANY SNAPSHOT (2021) 325
12.2.8 CUREMD HEALTHCARE 330
TABLE 245 CUREMD HEALTHCARE: BUSINESS OVERVIEW 330
12.2.9 BOGARDUS MEDICAL SYSTEMS, INC. 332
TABLE 246 BOGARDUS MEDICAL SYSTEMS, INC.: BUSINESS OVERVIEW 332
12.2.10 OPTUM (UNITEDHEALTH GROUP) 333
TABLE 247 OPTUM: BUSINESS OVERVIEW 333
FIGURE 61 OPTUM: COMPANY SNAPSHOT (2021) 333
12.2.11 MICA INFORMATION SYSTEMS, INC. 335
TABLE 248 MICA INFORMATION SYSTEMS, INC.: BUSINESS OVERVIEW 335
12.2.12 ADVANCED DATA SYSTEMS 336
TABLE 249 ADVANCED DATA SYSTEMS: BUSINESS OVERVIEW 336
12.2.13 ENDOSOFT LLC 337
TABLE 250 ENDOSOFT LLC: BUSINESS OVERVIEW 337
12.2.14 ALTAI ONCOLOGY, LLC 338
TABLE 251 ALTAI ONCOLOGY, LLC: BUSINESS OVERVIEW 338
12.2.15 MIM SOFTWARE INC. 339
TABLE 252 MIM SOFTWARE INC.: BUSINESS OVERVIEW 339
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
13 APPENDIX 341
13.1 DISCUSSION GUIDE 341
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 348
13.3 AVAILABLE CUSTOMIZATIONS 350
13.4 RELATED REPORTS 350
13.5 AUTHOR DETAILS 351
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security